ASM Results

Page 1 of 1 8 September 2020 Results of 2020 Annual Shareholder Meeting At AFT Pharmaceuticals Limited's (NZX: AFT / ASX: AFP) annual shareholder meeting held virtually today, shareholders were asked to vote on two resolutions, both of which were supported by the Board. As required by NZX Listing Rule 6.1, all voting was conducted by a poll. The resolutions passed by shareholders were: 1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2021 financial year. 2. That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited. Detail of the total number of votes cast in person or by a proxy holder are: Resolution For Against Abstain 1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2021 financial year. 87,540,520 99.99% 11,972 0.01% 2,000 2. That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited. 87,552,227 100.00% 1,145 0.00% 120 Authority for this announcement Name of person authorised to make this announcement Malcolm Tubby, Chief Financial Officer Contact person for this announcement Malcolm Tubby Contact phone number +64 9 488 0232 Contact email address Investor.relations@aftpharm.com Date of release through MAP 8 September 2020 End CA:00359428 For:AFT Type:MEETING Time:2020-09-08 16:11:25